← All organizations

Covidien

For profitContributed to NMEWebsite ↗

Also known as: COVIDIEN

Last known activity

Jul 29, 1981

Acquired by Medtronic on Aug 4, 2014

Timeline

1980s

  1. Jul 29, 1981

    isosulfan blue— NDA Organization

  2. Jul 29, 1981

    isosulfan blue— NDA Secondary Org

2000s

  1. Jan 1, 2007

    Covidien— Founded

  2. Mar 1, 2009

    Bacchus Vascular— Acquired

2010s

  1. Jun 1, 2010

    ev3— Acquired

  2. Apr 6, 2012

    Oridion— Acquired

  3. Feb 19, 2013

    Nfocus Neuromedical— Acquired

  4. Nov 1, 2013

    Beacon Endoscopic— Acquired

  5. Dec 9, 2013

    Given Imaging Ltd.— Acquired

  6. Apr 11, 2014

    New Wave Surgical— Acquired

  7. Aug 4, 2014

    Medtronic— Acquired By

  8. Aug 22, 2014

    Reverse Medical— Acquired

  9. Aug 28, 2014

    Sapheon— Acquired

Drugs by trial phase (10 distinct, 7 trials)

Phase 4 (0 own, 1 via acquisition)

Phase 3 (0 own, 1 via acquisition)

Phase 2 (0 own, 2 via acquisition)

Phase 1 (0 own, 4 via acquisition)

Other trials (0 own, 2 via acquisition)

Marketed drugs (1)

Subsidiaries (9 direct, 12 total across the full acquisition tree)

Details

Founded
Dublin, IE Jan 1, 2007
Last known activity
Jul 29, 1981